Skip to Main Content

Could improving sleep boost a soldier’s recovery from post-traumatic stress disorder?

New York drug maker Tonix Pharma seems to think so; it’s testing a long-approved muscle relaxant, cyclopenzaprine, as a way to help calm the brain before sleep to subdue PTSD symptoms. The company just got breakthrough designation from the Food and Drug Administration, and will be entering Phase 3 trials in patients with military-related PTSD in the first quarter of 2017.


We spoke with Tonix CEO Dr. Seth Lederman:

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.